News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
322,513 Results
Type
Article (11688)
Company Profile (50)
Press Release (310775)
Section
Business (108297)
Career Advice (664)
Deals (17830)
Drug Delivery (22)
Drug Development (35194)
Employer Resources (57)
FDA (5575)
Job Trends (6550)
News (166935)
Policy (11488)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Standard (1)
2024 Genetown Standard (3)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 Pharm Country Standard (1)
Academia (1105)
Adcomms (5)
Allergies (28)
Alliances (23237)
ALS (33)
Alzheimer's disease (643)
Antibody-drug conjugate (ADC) (22)
Approvals (5588)
Artificial intelligence (93)
Autoimmune disease (2)
Automation (6)
Bankruptcy (121)
Best Places to Work (5271)
BIOSECURE Act (1)
Biosimilars (21)
Biotechnology (42)
Bladder cancer (23)
Brain cancer (14)
Breast cancer (113)
Cancer (831)
Cardiovascular disease (65)
Career advice (578)
Career pathing (10)
CAR-T (56)
Cell therapy (167)
Cervical cancer (4)
Clinical research (28267)
Collaboration (317)
Compensation (154)
Complete response letters (4)
COVID-19 (938)
CRISPR (20)
C-suite (131)
Cystic fibrosis (44)
Data (927)
Denatured (1)
Depression (14)
Diabetes (77)
Diagnostics (3081)
Digital health (4)
Diversity, equity & inclusion (18)
Drug discovery (41)
Drug pricing (14)
Drug shortages (3)
Duchenne muscular dystrophy (29)
Earnings (44856)
Editorial (7)
Employer branding (10)
Employer resources (55)
Events (53571)
Executive appointments (390)
FDA (5950)
Featured Employer (18)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (1)
Frontotemporal dementia (4)
Funding (318)
Gene editing (39)
Generative AI (10)
Gene therapy (103)
GLP-1 (236)
Government (1213)
Guidances (23)
Healthcare (7876)
Huntington's disease (4)
IgA nephropathy (7)
Immunology and inflammation (28)
Indications (11)
Infectious disease (978)
Inflammatory bowel disease (62)
Inflation Reduction Act (2)
Influenza (13)
Intellectual property (28)
Interviews (84)
IPO (8761)
IRA (8)
Job creations (1524)
Job search strategy (529)
Kidney cancer (8)
Labor market (8)
Layoffs (164)
Leadership (6)
Legal (2914)
Liver cancer (29)
Lung cancer (102)
Lymphoma (54)
Management (19)
Manufacturing (85)
MASH (28)
Medical device (5140)
Medtech (5142)
Mergers & acquisitions (9304)
Metabolic disorders (215)
Multiple sclerosis (18)
NASH (6)
Neurodegenerative disease (28)
Neuropsychiatric disorders (8)
Neuroscience (839)
NextGen: Class of 2025 (2646)
Non-profit (1923)
Northern California (1137)
Now hiring (6)
Obesity (112)
Opinion (71)
Ovarian cancer (24)
Pain (23)
Pancreatic cancer (25)
Parkinson's disease (59)
Partnered (8)
Patents (50)
Patient recruitment (41)
Peanut (12)
People (35688)
Pharmaceutical (13)
Pharmacy benefit managers (1)
Phase I (8464)
Phase II (12134)
Phase III (9834)
Pipeline (514)
Podcasts (3)
Policy (22)
Postmarket research (1087)
Preclinical (4318)
Press Release (69)
Prostate cancer (44)
Psychedelics (13)
Radiopharmaceuticals (143)
Rare diseases (139)
Real estate (2707)
Recruiting (21)
Regulatory (8017)
Reports (15)
Research institute (1183)
Resumes & cover letters (90)
Rett syndrome (2)
RNA editing (1)
RSV (5)
Schizophrenia (33)
Series A (69)
Series B (28)
Sickle cell disease (24)
Southern California (921)
Special edition (2)
Sponsored (14)
Startups (1824)
State (1)
Stomach cancer (3)
Supply chain (16)
The Weekly (2)
United States (9582)
Vaccines (152)
Venture capitalists (10)
Webinars (6)
Weight loss (49)
Women's health (8)
Worklife (1)
Date
Today (29)
Last 7 days (293)
Last 30 days (1400)
Last 365 days (16450)
2025 (2943)
2024 (17276)
2023 (20111)
2022 (26818)
2021 (28920)
2020 (26644)
2019 (20541)
2018 (15820)
2017 (15761)
2016 (14731)
2015 (17940)
2014 (13793)
2013 (10950)
2012 (11605)
2011 (12284)
2010 (11593)
Location
Africa (305)
Alabama (20)
Alaska (5)
Arizona (80)
Arkansas (3)
Asia (16829)
Australia (2639)
California (2471)
Canada (965)
China (122)
Colorado (121)
Connecticut (132)
Delaware (45)
Europe (39938)
Florida (328)
Georgia (68)
Idaho (28)
Illinois (177)
India (5)
Indiana (103)
Iowa (1)
Japan (78)
Kansas (31)
Kentucky (13)
Louisiana (6)
Maine (40)
Maryland (312)
Massachusetts (2072)
Michigan (144)
Minnesota (153)
Mississippi (1)
Missouri (38)
Montana (18)
Nebraska (15)
Nevada (28)
New Hampshire (24)
New Jersey (718)
New Mexico (21)
New York (741)
North Carolina (446)
North Dakota (3)
Northern California (1137)
Ohio (101)
Oklahoma (6)
Oregon (20)
Pennsylvania (526)
Puerto Rico (2)
Rhode Island (18)
South America (424)
South Carolina (5)
Southern California (921)
Tennessee (41)
Texas (343)
Utah (95)
Virginia (51)
Washington D.C. (13)
Washington State (230)
West Virginia (2)
Wisconsin (28)
322,513 Results for "kewaunee scientific corporation".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025
March 13, 2025
·
18 min read
Press Releases
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2025
February 27, 2025
·
4 min read
Press Releases
Kewaunee Scientific Corporation Completes Acquisition of Nu Aire
November 4, 2024
·
7 min read
Business
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter 2024
Kewaunee Scientific Corporation announced results for its fourth quarter and its fiscal year ended April 30, 2024.
June 26, 2024
·
21 min read
Press Releases
Kewaunee Scientific Reports Results for Second Quarter of Fiscal Year 2025
December 12, 2024
·
16 min read
Press Releases
Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2025
November 27, 2024
·
4 min read
Business
Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2024
Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced results for its third quarter ended January 31, 2024.
March 6, 2024
·
11 min read
Business
Kewaunee Scientific Corporation Announces Attendance at the 2024 Arablab Live Tradeshow and Conference
September 4, 2024
·
4 min read
Business
Kewaunee Scientific to Report Results for Third Quarter Fiscal Year 2024
Kewaunee Scientific Corporation (NASDAQ: KEQU) today announced that the Company plans to release its third quarter fiscal year 2024 financial results on Wednesday, March 6, 2024 after the close of trading.
February 21, 2024
·
3 min read
Business
Kewaunee Scientific Reports Results for First Quarter of Fiscal Year 2025
September 11, 2024
·
12 min read
1 of 32,252
Next
